Kurokawa M - Search Results

1

High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.

Asano-Mori Y, Oshima K, Sakata-Yanagimoto M, Nakagawa M, Kandabashi K, Izutsu K, Hangaishi A, Motokura T, Chiba S, Kurokawa M, Hirai H, Kanda Y. Asano-Mori Y, et al. Among authors: kurokawa m. Bone Marrow Transplant. 2005 Nov;36(9):813-9. doi: 10.1038/sj.bmt.1705134. Bone Marrow Transplant. 2005. PMID: 16151428

2

An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.

Tanaka T, Tanaka K, Ogawa S, Kurokawa M, Mitani K, Nishida J, Shibata Y, Yazaki Y, Hirai H. Tanaka T, et al. Among authors: kurokawa m. EMBO J. 1995 Jan 16;14(2):341-50. doi: 10.1002/j.1460-2075.1995.tb07008.x. EMBO J. 1995. PMID: 7530657 Free PMC article.

3

Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells.

Tanaka K, Tanaka T, Ogawa S, Kurokawa M, Mitani K, Yazaki Y, Hirai H. Tanaka K, et al. Among authors: kurokawa m. Biochem Biophys Res Commun. 1995 Jun 26;211(3):1023-30. doi: 10.1006/bbrc.1995.1913. Biochem Biophys Res Commun. 1995. PMID: 7598688

4

Growth inhibition of leukaemic cells carrying the t(3;21) by the AML1/EVI-1-specific antisense oligonucleotide.

Mitani K, Ogawa S, Tanaka T, Kurokawa M, Yazaki Y, Hirai H. Mitani K, et al. Among authors: kurokawa m. Br J Haematol. 1995 Jul;90(3):711-4. doi: 10.1111/j.1365-2141.1995.tb05606.x. Br J Haematol. 1995. PMID: 7647015

5

The AML1/Evi-1 fusion protein in the t(3;21) translocation exhibits transforming activity on Rat1 fibroblasts with dependence on the Evi-1 sequence.

Kurokawa M, Ogawa S, Tanaka T, Mitani K, Yazaki Y, Witte ON, Hirai H. Kurokawa M, et al. Oncogene. 1995 Sep 7;11(5):833-40. Oncogene. 1995. PMID: 7675444

6

Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21) leukemias.

Tanaka T, Mitani K, Kurokawa M, Ogawa S, Tanaka K, Nishida J, Yazaki Y, Shibata Y, Hirai H. Tanaka T, et al. Among authors: kurokawa m. Mol Cell Biol. 1995 May;15(5):2383-92. doi: 10.1128/MCB.15.5.2383. Mol Cell Biol. 1995. PMID: 7739522 Free PMC article.

7

Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias.

Ogawa S, Hirano N, Sato N, Takahashi T, Hangaishi A, Tanaka K, Kurokawa M, Tanaka T, Mitani K, Yazaki Y, et al. Ogawa S, et al. Among authors: kurokawa m. Blood. 1994 Oct 15;84(8):2431-5. Blood. 1994. PMID: 7919362 Free article.

8

Generation of the AML1-EVI-1 fusion gene in the t(3;21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia.

Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H. Mitani K, et al. Among authors: kurokawa m. EMBO J. 1994 Feb 1;13(3):504-10. doi: 10.1002/j.1460-2075.1994.tb06288.x. EMBO J. 1994. PMID: 8313895 Free PMC article.

9

Overexpression of the AML1 proto-oncoprotein in NIH3T3 cells leads to neoplastic transformation depending on the DNA-binding and transactivational potencies.

Kurokawa M, Tanaka T, Tanaka K, Ogawa S, Mitani K, Yazaki Y, Hirai H. Kurokawa M, et al. Oncogene. 1996 Feb 15;12(4):883-92. Oncogene. 1996. PMID: 8632911

10

Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.

Ogawa S, Kurokawa M, Tanaka T, Tanaka K, Hangaishi A, Mitani K, Kamada N, Yazaki Y, Hirai H. Ogawa S, et al. Among authors: kurokawa m. Leukemia. 1996 May;10(5):788-94. Leukemia. 1996. PMID: 8656673

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,546 results

Search Page

Filters